MediView XR is a Cleveland-based med-tech company commercializing an augmented-reality ecosystem that fuses pre-operative CT data with live ultrasound to give clinicians ‘X-ray vision’ during interventions. Its FDA-cleared XR90 platform projects a 3D model of a patient’s internal anatomy directly onto the body, enabling head-up, hands-free guidance for biopsies, tumor ablations, injections, and other image-guided procedures. The system reduces physicians’ cognitive load by eliminating the need to translate 2D images into 3D mental maps and supports remote collaboration among care teams. MediView’s technology originated from Cleveland Clinic intellectual property and is positioned to become a new standard for less invasive care. With fresh capital, the company plans to accelerate commercial roll-out, expand industry partnerships, pursue additional regulatory approvals, and deepen AI-driven product development. Operational capacity will be scaled to meet increasing global demand. No revenue or user metrics were disclosed in the article.

Total raised

$44M

Funding rounds

3

Latest round

Series A

Latest activity

Oct 2025